Optic Nerve Head Strain as Biomarker for Glaucoma
Launched by JOHNS HOPKINS UNIVERSITY · Feb 2, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how images of the optic nerve head (the part of the eye where the optic nerve connects) can help predict the progression of glaucoma, a common eye condition that can lead to vision loss. Researchers will take pictures of the optic nerve at two different eye pressures to see how much strain is present, which may provide important information about how the disease will develop in each patient.
To participate in this study, individuals must already have a diagnosis of glaucoma and be patients at Johns Hopkins. The trial is open to adults aged 65 to 87. However, some people may not be eligible, such as those who cannot undergo imaging for any reason or those who have difficulties with reading or hearing. Participants can expect to have their eye images taken and will contribute to important research that could improve understanding and treatment of glaucoma in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Existing glaucoma patients of Johns Hopkins
- Exclusion Criteria:
- • Inability to perform imaging
- • illiterate
- • hearing impaired
- • non-English speakers
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Harry Quigley
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported